Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 372

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Cell cycle on the crossroad of tumorigenesis and cancer therapy

Open access
Liu, Jing, Peng, Yunhua, Wei, Wenyi·2022·Trends in Cell Biology

Abstract

Aberrancy in cell cycle progression is one of the fundamental mechanisms underlying tumorigenesis, making regulators of the cell cycle machinery rational anti-cancer therapeutic targets. Growing body of evidence indicates that the cell cycle regulatory pathway integrates into other hallmarks of cancer, including metabolism remodeling and immune escaping. Thus, therapies against cell cycle machinery components can not only repress the division of cancer cells, but also reverse cancer metabolism and restore cancer immune surveillance. Apart from the ongoing effects on developing small molecule inhibitors (SMIs) of cell cycle machinery, PROTACs have recently been used for targeting these oncogenic proteins related to cell cycle progression. Here, we discuss the rationale of cell cycle targeting therapies, particularly PROTACs, to more efficiently retard tumorigenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tcb.2021.07.001

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 103 references

Cited by

See all 372

Metadata

Authors
Liu, J., Peng, Y., & Wei, W.
Venue
Trends in Cell Biology
Publisher
Elsevier BV
Published
2022-01
Volume
32
Issue
1
Pages
30-44
ISSN
0962-8924 (ISSN-L)
OpenAlex
W3184439942
Cited by
372
References
103
FWCI
9.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cell cycle on the crossroad of tumorigenesis and cancer therapy. https://app.cochat.ai/papers/10.1016/j.tcb.2021.07.001
The paper
Liu, J., Peng, Y., & Wei, W. (2022). Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends in Cell Biology. https://doi.org/10.1016/j.tcb.2021.07.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.